Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial
Top Cited Papers
- 1 October 2016
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 17 (10) , 1374-1385
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Merkel Cell Carcinoma: Chemotherapy and Emerging New Therapeutic OptionsJournal of Skin Cancer, 2013
- Improved detection suggests all Merkel cell carcinomas harbor Merkel polyomavirusJournal of Clinical Investigation, 2012
- Merkel Cell Polyomavirus-Specific CD8+ and CD4+ T-cell Responses Identified in Merkel Cell Carcinomas and BloodClinical Cancer Research, 2011
- Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: Analysis of 5823 cases as the basis of the first consensus staging systemJournal of the American Academy of Dermatology, 2010
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response CriteriaClinical Cancer Research, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU featuresJournal of the American Academy of Dermatology, 2008
- Clonal Integration of a Polyomavirus in Human Merkel Cell CarcinomaScience, 2008
- MERKEL CELL CARCINOMA: IMPROVED OUTCOME WITH ADJUVANT RADIOTHERAPYAnz Journal of Surgery, 2005
- Epidemiology of primary Merkel cell carcinoma in the United StatesJournal of the American Academy of Dermatology, 2003